Filing Details
- Accession Number:
- 0000721371-23-000068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-17 19:49:37
- Reporting Period:
- 2023-08-15
- Accepted Time:
- 2023-08-17 19:49:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 721371 | Cardinal Health Inc | CAH | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 310958666 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1945228 | D. Michelle Greene | 7000 Cardinal Place Dublin OH 43017 | Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2023-08-15 | 1,239 | $92.99 | 12,416 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2023-08-16 | 10,398 | $0.00 | 22,814 | No | 4 | A | Direct | |
| Common Shares | Disposition | 2023-08-17 | 2,000 | $86.79 | 20,814 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 2,682 restricted share units ("RSUs").
- Reflects closing price on prior business day.
- Grant of restricted share units RSUs that vest in three equal annual installments beginning on August 15, 2024.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.65 to $86.92, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
Billionaire Hedge Funds
